Assisted Reproduction Technology Treatment Outcomes in Female Carriers of 21-Hydroxylase Deficiency

Medical Journal

Apr 2

Written By Abby Hunt

Arcaz AC, Hernandez-Nieto C, Lee JA, Cacchione TA, Mukherjee T, Copperman AB. Assisted Reproduction Technology Treatment Outcomes in Female Carriers of 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2025 Apr 2:dgaf198. doi: 10.1210/clinem/dgaf198. Epub ahead of print. PMID: 40171917.

Abby Hunt

In vitro fertilization with cryopreserved oocytes or embryos after cancer: The role of gestational carriers

Dietary advanced glycation end products (AGEs) and superovulation with gonadotropins alter RAGE expression in the ovaries differently at each follicular stage of development

Fertility Centers of Illinois (Copy)

IVF Florida (Copy)

Ovation Fertility (Copy)

RMA of New York (Copy)

Shady Grove Fertility (Copy)

About News Careers Contact

Terms & Conditions Privacy Statement Public Notices

Copyright © 2025 US Fertility